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Studies were carried out to evaluate the proposed role of indoleamine 2,3-dioxygenase (INDO) induction in
the antimicrobial and antiproliferative effects of gamma interferon (IFN-y) in human fibroblasts. The INDO
cDNA coding region was cloned in the pMEP4 expression vector, containing the metallothionein (MTII)
promoter in the sense (+ve) or the antisense (-ve) orientation. Human fibroblasts (GM637) stably transfected
with the sense construct expressed INDO activity after treatment with CdCl2 or ZnSO4, but cells transfected
with the antisense construct did not. The growth of Chiamydia psittaci was strongly inhibited in INDO +ve cells
but not in INDO -ve cells after treatment with Cd2+ or Zn2+. The inhibition correlated with the level ofINDO
activity induced and could be reversed by the addition of excess tryptophan to the medium. The growth of
Toxoplasma gondii was also strongly inhibited in INDO +ve cells but not in INDO -ve cells after treatment
with Cd2+. Expression of Cd2+-induced INDO activity also inhibited thymidine incorporation and led to
cytotoxicity in INDO +ve cells but not in INDO -ve cells. Thus, the induction of INDO activity by IFN--y may
be an important factor in the antimicrobial and antiproliferative effects of IFN--y in human fibroblasts.
Gamma interferon (IFN--y), a cytokine produced by acti-
vated T lymphocytes and natural killer cells, has pleiotropic
effects; it plays a vital role in host self-defense against a variety
of nonviral microbial pathogens, regulates immune responses,
and inhibits cell growth (10, 37). Administration of neutraliz-
ing antibodies against IFN--y abrogates the resistance of mice
to various microbial pathogens (3, 4, 34, 40), indicating a
primary role of IFN-y in host defense against such pathogens.
IFN-y induces the synthesis of a number of gene products in
cells (38). Several of the induced gene products have been
implicated in the IFN-y-mediated resistance to microbial
infection. This includes the production of nitric oxide resulting
from the induction of nitric oxide synthase (1, 14, 21, 24),
activation of macrophages (22, 23), and starvation for trypto-
phan due to induction of the indoleamine 2,3-dioxygenase
(INDO) enzyme (6, 7a, 26, 27, 33), which catalyzes the first
step in tryptophan degradation. (The office of Human Gene
Mapping nomenclature [Department of Human Genetics,
University of Manitoba, Canada] brought to our attention that
the term IDO had been assigned to indole 2,3-dioxygenase [EC
1.13.11.17]. Indoleamine 2,3-dioxygenase [EC 1.13.11.42] has
therefore been abbreviated INDO.)
Since a variety of gene products are induced by IFN-y, their
relative importance in the biological effects of IFN-y is difficult
to determine. To assess the significance of INDO as a part of
this host resistance mechanism, we cloned cDNA for human
INDO (8) in an expression vector containing the metallothio-
nein (MTII) promoter. Cells transfected with this construct
provide a way to induce INDO activity independent of other
IFN-y-induced proteins. We have examined whether expres-
sion of INDO activity in cells stably transfected with the INDO
* Corresponding author. Mailing address: Hipple Cancer Research
Center, 4100 S. Kettering Blvd.. Dayton, OH 45439. Phone: (513)
293-8508. Fax: (513) 293-7652.
cDNA expression plasmid would inhibit the growth of Chla-
mydia psittaci and Toxoplasma gondii in the absence of IFN-y,
which would demonstrate whether the expression of INDO
alone can block the replication of these pathogens. In addition,
we have tested whether the expression of INDO in transfected
cells would also result in cytostatic and cytotoxic effects, as
observed after treatment with IFN-y (9, 25, 30, 35, 36).
MATERIALS AND METHODS
Cloning of INDO cDNA in an inducible expression vector. A
nearly full-length, ca. -2-kb INDO cDNA was cloned origi-
nally in plasmid Bluescript SK- and named C42 (8). In order
to express this cDNA in mammalian cells, it was first recloned
in an expression vector. We chose vector pMEP4 (Invitrogen,
San Diego, Calif.), based on the Epstein-Barr virus, because of
the presence of the inducible metallothionein (MTII) pro-
moter and its ability to replicate to a high copy number. The
INDO cDNA contained more than 600 nucleotides of 5'
untranslated sequence. Therefore, in order to obtain optimal
expression of INDO enzyme, we decided to clone (i) the
full-length cDNA, including >600 bp of untranslated 5' se-
quence, and (ii) the coding region after deletion of most of this
untranslated sequence. In both cases, the cDNA was cloned in
the sense orientation as well as the antisense orientation with
respect to the MTII promoter. The 2-kb insert was obtained by
digestion of plasmid C42 with KpnI plus NotI enzymes and
cloned into the pMEP4 vector digested with the same enzymes
to insert the INDO cDNA in the sense orientation (see Fig. 1).
For cloning in the antisense orientation, the 2-kb cDNA was
obtained by digestion of plasmid C42 with XhoI plus SmaI
enzymes and ligated to pMEP4 digested with XhoI plus PvuII
enzymes. After transformation of Escherichia coli DHl cells
with each of the two constructs, several colonies were isolated,
and plasmid minipreps were prepared and analyzed for the
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FIG. 1. INDO cDNA (ca. -2 kb) cloned into Bluescript SK- at the EcoRI site (A) was isolated either in its entirety or as a 1.4-kb subfragment
after deletion of 592 bp of 5' untranslated sequence as described in Materials and Methods and cloned into the pMEP4 vector (B) containing the
metallothionein (MT II) promoter in both the sense and antisense orientations. (The Bluescript vector map has been reproduced with the
permission of Stratagene, and the pMEP4 map has been reproduced with the permission of Invitrogen.) MCS, multiple cloning site.
presence of the insert and its orientation with respect to the
MTII promoter by restriction analysis. Separately, a ca.
-1.4-kb INDO cDNA fragment containing the entire coding
sequence but depleted of much of the untranslated 5' sequence
was isolated by making use of an XmnI site at position 592
from the 5' end of the 2-kb INDO cDNA insert. Plasmid C42
was digested with XmnI and then with XhoI and SmaI en-
zymes. This allowed the isolation of a 1.4-kb fragment with
both ends blunt (XmnI and SmaI). (The XhoI digestion was
included because the vector also has an XmnI site which
yielded another fragment of approximately the same size that
could be cleaved by XhoI to facilitate the isolation of the
INDO 1.4-kb fragment.) The 1.4-kb fragment isolated after
agarose gel electrophoresis was ligated to the pMEP4 vector
digested with PvuII enzyme. After transformation of DH1
cells, plasmid minipreps were obtained from several colonies
and analyzed to determine the presence of the 1.4-kb insert
and its orientation with respect to the MTII promoter by
restriction analysis. Clones containing the 2-kb cDNA as well
as the 1.4-kb cDNA insert in both the sense and antisense
orientations with respect to the MTII promoter were obtained
and grown at a preparative scale, and the plasmids were
purified by previously described procedures (31).
Stable transfection of human fibroblasts with INDO cDNA
cloned in pMEP4 expression vector. Transformed human
fibroblast cell line GM637 was obtained from the Coriell
Institute for Medical Research, Camden, N.J., and maintained
in Eagle's minimal essential medium (MEM) supplemented
with penicillin (100 U/ml), streptomycin (100 jLg/ml), and 10%
fetal bovine serum (FBS). Individual cultures of GM637 cells
were transfected with plasmid preparations containing either
the 2-kb INDO cDNA or the 1.4-kb fragment containing the
INDO coding region in either the sense or the antisense
orientation. The calcium phosphate coprecipitation method
was used for transfection of cells (2), and the transformants
were selected with hygromycin (250 U/ml), as the vector
contains the hygromycin resistance gene. Cells stably trans-
fected with each of the four plasmid constructs were obtained
and maintained in the presence of hygromycin (250 U/ml).
Stocks of C. psittaci and T. gondii. Stocks of C. psittaci 6BC
were propagated in confluent L929 mouse cell monolayers in
M199 medium supplemented with 10% FBS, 10 ,ug of genta-
micin sulfate per ml, 100 jLg of streptomycin sulfate per ml, and
2 ,ug of cycloheximide per ml at 37°C in 5% CO2 in air. The
cells were infected with 10 times the 50% infectious dose
(ID50) of 6BC, incubated for 2 days, and removed from the
tissue culture plate with trypsin. Infected cells were then
disrupted by sonication, and elementary bodies were partially
purified by differential centrifugation, resuspended in phos-
phate-buffered saline (PBS) containing 0.2 M sucrose and 2%
FBS, distributed into cryovials, and frozen at -70°C until
needed. Infectivity titers were quantified by the ID50 method in
L cells (16). A cloned line of the RH strain of T. gondii was
maintained in normal human fibroblast cultures as described
previously (29).
Replication of C. psittaci and T. gondii in transfected cells.
For experiments on C. psittaci replication, cells transfected
with the sense or antisense INDO construct were cultivated in
24-well plates on cover slips in triplicate wells (2 x 105 cells per
well) in Eagle's MEM supplemented with 10% FBS, 100 ,ug of
gentamicin sulfate per ml, and 10 jig of streptomycin sulfate
per ml. Some wells received ZnSO4 or CdCl2 at final concen-
trations of 75 and 5 ,uM, respectively. In experiments measur-
ing the effect of metal ion concentration on INDO induction
and inhibition of chlamydiae, half-log dilutions of the metal ion
inducers were used. After 24 h of incubation, cells were
infected with 0.3 ID50s of C. psittaci in 50 -jil of Hanks'
balanced salt solution (HBSS), which resulted in infection of
between 30 and 50% of the cells. Incubation was continued for
an additional 24 h to permit sufficient development of chla-
mydial inclusions. After incubation, cover slips from these
wells were washed with PBS, fixed with methanol, stained with
5% Giemsa, and mounted on slides. The percentage of C.
psittaci inclusion-containing cells was determined by light
microscopy (5).
For experiments on T. gondii replication, transfected cells
were grown in Eagle's MEM supplemented with 10% FBS,
antibiotics, and 250 U of hygromycin per ml. Cells were washed
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three times with PBS, trypsinized, and pelleted by centrifuga-
tion. The cells were suspended in medium containing 5% FBS
and seeded in 0.5-cm2 wells at a density calculated to yield a
confluent monolayer without further cell division. The next
day, the cultures were incubated in medium either without or
with CdCl2 added. After 2 days, both treated and control
cultures were supplemented with EDTA (45 p.M) to chelate
Cd2+ ions. The addition of EDTA was essential to block the
inhibitory effect of Cd2 t on the growth of the parasite. The
cultures were then infected with 1.5 x 104 T gondii, and the
growth of the parasite was measured 2 days later by adding 0.6
p.Ci of [5,6_-3H]uracil (specific activity, 20 Ci/mmol; Moravek
Biochemicals) and measuring the acid-precipitable radioactiv-
ity 4 h later, as described previously (28).
Effect of exogenous tryptophan on INDO-mediated inhibi-
tion of C. psittaci replication. Transfected cell cultures were
treated with inducers or medium alone and infected with C.
psittaci as described above. After a 2-h incubation, serial log
dilutions of tryptophan in HBSS or HBSS alone was added to
the culture medium. After an additional 24 h., cover slips were
fixed and stained, and chlamydial growth was determined.
Determination of INDO activity in transfected cells. INDO
activity was determined in transfected cell cultures set up in
parallel to cultures infected with C. psittaci. After 44 h of
incubation, the culture medium was aspirated and replaced
with 400 pl of 50 F.M tryptophan in HBSS containing I ,uCi of
[5_-3H]tryptophan (specific activity, 20 to 30 Ci/mmol; New
England Nuclear) per ml. Some wells received radiolabeled
medium without cells to determine the amount of nonspecific
tryptophan decyclization that occurred. After 4 h of incuba-
tion, supernatants were collected and frozen at -20°C until
analyzed for accumulated tryptophan metabolites. INDO ac-
tivity was assessed by a modification of a reversed-phase
high-performance liquid chromatographic (HPLC) technique
(39). Briefly, 50-pl aliquots of culture supernatants were
injected into a ,uBondapak CI, column (30 cm by 3.9-mm inner
diameter) (Millipore Waters, Milford, Mass.) and eluted with
10% methanol in 1 mM KH2PO4 buffer, pH 4.0, at a flow rate
of 1.6 ml/min. Radioactivity was measured by integration of
peak areas with a fully automated HPLC (Isco, Lincoln, Neb.)
equipped with a radioisotope detector (Radiomatic Instru-
ments, Tampa, Fla.). The percentage of specific tryptophan
catabolism was calculated by the following equation:
% specific catabolism = CPMtcSt
CPMspontancous
lrl"AIl "? It x 100 (1)
LI'Mtotal (LIMspontancous
where CPMtCs, is the counts per minute (CPM) present in
N-formylkynurenine and kynurenine-containing fractions,
CPMSpO,ntf,,lCOLIS represents the CPM of nonspecific tryptophan
degradation products, and CPM,(,,1, is the sum of CPM from
all fractions (7a).
Effect of INDO expression on cell growth. Cells transfected
with the 1.4-kb INDO cDNA coding region in either the sense
or antisense orientation were seeded in 24-well tissue culture
plates (4 x l04 cells per well). The next day, duplicate wells
were treated with either IFN-y (250 U/ml) or Cd2+ (5 ,uM) or
left untreated (controls). To measure the effect on cell growth,
cells were labeled with [3H]thymidine (3 pCi per well) for 2 h
on day 3 or day 5 from the start of treatment. The medium was
then removed, and the cells were washed with cold PBS and
solubilized in 0.2 ml of 1 N NaOH. Aliquots of each sample
were used for determination of trichloroacetic acid-precipita-
ble counts in duplicate.
RESULTS
Stable transfection of human fibroblasts with INDO cDNA
cloned in pMEP4 expression vector. Cultures of GM637 cells
were transfected with plasmid preparations containing either
the 2-kb INDO cDNA or the 1.4-kb fragment containing the
INDO coding region cloned in the pMEP4 vector in either the
sense or antisense orientation with respect to the MTII
promoter, as described in Materials and Methods. In parallel,
cells were transfected with pMEP4 vector alone, and the
transformants were selected with hygromycin (250 U/mI), as
the vector contains the hygromycin resistance gene. Cells
stably transfected with each of the four plasmid constructs
were obtained and maintained in the presence of hygromycin
(250 U/ml).
Cultures of stably transfected cells were tested for the
expression of INDO activity after treatment with CdCl, (0 to
10 F.M) or ZnSO4 (0 to 75 ,uM) or with IFN-y (250 U/ml) for
24 h. Cells were then washed, and the medium was replaced
with Earle's basal salt solution containing tryptophan (100
F.M) and 10% FBS. After incubation for a further 24 h, the
medium was collected and assayed for kynurenine by a colo-
rimetric assay as described before (11). We found that INDO
activity was strongly induced in cells transfected with the
plasmid containing the 1.4-kb INDO coding region in the sense
orientation after treatment with Cd2 or Zn2+ in a concentra-
tion-dependent manner. Stronger induction was obtained with
Cd2+, reaching a maximum at 5 to 10 p.M, which was compa-
rable to the level of INDO activity induced (from the cellular
INDO gene) after treatment with 250 U of IFN-y per ml (Fig.
2A). Cells transfected with the plasmid containing the 1.4-kb
INDO coding region in the antisense orientation showed no
detectable INDO activity after treatment with Cd2-t, as ex-
pected for the antisense construct, but responded normally to
IFN--y (Fig. 2A).
By Northern (RNA blot) analysis, INDO-specific RNA
transcripts were found in cells transfected with either the sense
or antisense construct after treatment with CdCl2 (Fig. 2B).
The Cd2'-induced INDO transcripts from the transfected
plasmid constructs (Fig. 2B, lanes 3 and 6) were slightly longer
than the IFN-y-induced INDO transcripts from the cellular
gene (Fig. 2B, lanes 2 and 5), apparently because of the
contribution from the vector. The level of Cd24 -induced
INDO transcripts was lower in cells transfected with the
antisense construct (Fig. 2B, lane 6) than in cells transfected
with the sense construct (lane 3). This could be due to a shorter
half-life of the antisense transcripts. The cells transfected with
the plasmid containing the entire 2-kb INDO cDNA did not
express any measurable INDO activity when treated with
Cd2>, although RNA transcripts were found in Northern blots
(data not shown). We believe that this is due to the rather long
untranslated 5' sequence in the 2-kb clone, which contains
termination codons in each reading frame (8). Therefore, the
studies reported here were carried out with cells transfected
with the 1.4-kb INDO cDNA constructs. The cells transfected
with the vector alone showed no Cd2'-induced INDO activity
but responded normally to IFN-y (not shown), as expected.
Inhibition of C. psittaci replication upon expression of INDO
activity. To determine whether the expression of INDO activ-
ity in transfected cells would have an effect on C. psittaci
infection, cells transfected with either the sense or antisense
INDO construct were treated with CdCl, (5 ,uM) or ZnSO4 (75
p.M) for 24 h and then infected with 0.3 ID51) of C. psittaci as
described in Materials and Methods. After incubation for a
further 24 h, cells were fixed and scored for percentage of
inclusion-containing cells by light microscopy (5). The results
VOL. 62, 1994
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FIG. 2. Expression of INDO cDNA in cells transfected with the
sense and antisense constructs. (A) Transfected cells were grown to
confluence in 24-well plates and then incubated either with IFN--y (250
U/ml; right panel) or with increasing concentrations of CdCI2 (0 to 10
FM; left panel) for 24 h. The cells were then washed with PBS and
incubated with 100 puM L-tryptophan in Earle's basal salt solution
containing 10% FBS for 24 h at 37°C. The medium was collected,
treated with 5% trichloroacetic acid at 50°C for 30 min, and centri-
fuged. The supernatant was assayed for L-kynurenine by adding an
equal volume of 0.4% Ehrlich's reagent in glacial acetic acid and
measuring the color developed by the A49(0 (11, 35). (B) Cells trans-
fected with the sense or antisense construct were grown in 100-mm
plates and treated with either IFN-,y (250 U/ml) or CdCl2 (5 F.M) for
24 h. Cells were washed with PBS, and total RNA was isolated by the
acid-phenol-chloroform extraction procedure (7b) and precipitated
with an equal volume of isopropanol. The precipitate was extracted
with 4 M LiCl2-l.5 M guanidine isothiocyanate-25 mM sodium citrate
(pH 7.0)-0.1 M 2-mercaptoethanol at 0 to 4°C for 2 h, washed with
75% ethanol, and then dissolved in 0.1% sodium dodecyl sulfate. A
15-pg amount of each sample was fractionated by electrophoresis in
1% agarose and transferred to a nitrocellulose membrane. The
membrane was baked and prehybridized and then hybridized with the
32P-labeled INDO cDNA probe. The membrane was washed and
autoradiographed as described before (7). The positions of the 28S and
18S rRNA markers are indicated.
showed that treatment with Cd2+ or Zn2+ strongly inhibited
the growth of C. psittaci in cells transfected with the sense
construct but not in cells transfected with the antisense con-
struct (Fig. 3). In the absence of heavy metal ions, both cell
types supported C. psittaci growth to a comparable extent. In
parallel cultures, tryptophan catabolism was assayed by HPLC
(39) as described in Materials and Methods. After treatment
with Cd2+ or Zn2T, a large part of the tryptophan in the
culture medium was catabolized in cells transfected with the
INDO sense construct but not in cells transfected with the
antisense construct (Fig. 3, bottom).
medium [Zn] 75 gM [Cd] 5gM
INDUCER
FIG. 3. Effect of Zn2 and Cd2 -on the induction of INDO activity
(lower panel) and the inhibition of C. psittaci (upper panel) in human
GM637 fibroblasts transfected with INDO cDNA cloned in the
pMEP4 expression vector in either the sense orientation (hatched
bars) or the antisense orientation (open bars). Infection with chlamyd-
iae is expressed as percentage of inclusion-containing cells + standard
deviation (SD), and INDO activity is represented as percent specific
catabolism + SD. See Materials and Methods for details.
The effects of the Cd2T and Zn2+ concentration on the
induction of INDO activity and the growth of chlamydiae in
cells transfected with the INDO sense construct are shown in
Fig. 4. The results showed that the level of INDO activity
induced (as measured by tryptophan catabolism) was depen-
dent on the Cd2T or Zn2+ concentration and that the inhibi-
tion of chlamydial inclusions upon treatment with increasing
concentrations of CdCI2 or ZnSO4 correlated closely with
tryptophan degradation. Complete inhibition was obtained at 5
,uM Cd2T and 75 ,.M Zn2T. In order to determine whether this
inhibition of chlamydial growth was indeed due to the deple-
tion of tryptophan, we tested whether it would be reversed by
the addition of excess tryptophan. The inhibitory effect ob-
served after treatment of INDO sense-transfected cells with
Cd2T (5 F.M) or Zn2T (75 FiM) was completely overcome by
the addition of 100 p.M L-tryptophan (Fig. 5), indicating that
induction of the transfected INDO gene construct caused
depletion of tryptophan and thus inhibited chlamydial growth
in these cells after treatment with Cd2T or Zn2+.
Inhibition of T. gondii replication in INDO-transfected cells.
The replication of T gondii in human fibroblasts is strongly
inhibited by treatment with IFN--y, which has been attributed
to tryptophan depletion due to induction of the INDO enzyme
(26, 27). Since IFN-y induces a number of gene products, we
tested whether the expression of INDO enzyme alone in
transfected cells would block the replication of T. gondii in the
absence of IFN-y. Cells transfected with the sense or antisense
INDO construct were incubated with or without CdCl2 (10
,uM) for 2 days. Then, EDTA was added to 45 p.M (final
INFECTr. IMMUN.
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FIG. 4. Effect of increasing concentrations of Cd2 (A) and Zn2
(B) on the induction of INDO activity (El) and the inhibition of
chlamydial growth (-) in cells transfected with the sense construct of
INDO cDNA (1.4 kb) in the pMEP4 vector. Chlamydial growth and
INDO activity are expressed as described in the legend to Fig. 2. Error
bars represent SD.
concentration) to chelate Cd ", which was inhibitory to T.
gondii replication, and the cultures were infected with T.
gondii. The growth of the parasite was measured by the
incorporation of [3H]uracil 2 days later. The results showed
>90% inhibition of T. gondii growth in cells transfected with
the sense construct after treatment with Cd2+. No inhibition of
T gondii growth was observed in cells transfected with the
antisense construct after treatment with Cd2 + (data not
shown).
While our studies were in progress, Habara-Ohkubo et al.
(15) reported that expression of mouse INDO cDNA in
murine cells blocked the growth of T gondii. Our experiments
showed a similar result with human INDO in human cells. In
view of this published report (15), we did not carry out any
further experiments to study the effect of INDO expression on
T. gondii growth.
INDO expression and cell growth. IFN-y has been shown to
have an antiproliferative effect on tumor cells in culture (9, 25,
30, 35, 36), which has been correlated with the induction of
INDO enzyme. We examined whether the expression of INDO
activity alone in transfected cells would have a cytostatic and/or
cytotoxic effect in the absence of IFN-y. Cells transfected with
FIG. 5. Inhibition of chlamydial growth by Cd2 ' and Zn-2 'in cells
transfected with the INDO cDNA sense construct and its reversal by
the addition of excess tryptophan. Error bars represent SD.
the sense or antisense INDO construct were seeded in 24-well
plates, and duplicate wells were treated with either IFN-y (250
U/ml) or CdCl, (5 [FM) or left untreated (control). The effect
on cell growth was determined by measuring the incorporation
of [3H]thymidine after 3 or 5 days. The results showed that
thymidine incorporation was strongly inhibited in cells trans-
fected with the INDO sense construct after treatment with
Cd2 (Fig. 6A) but not in cells transfected with the antisense
construct (Fig. 6B). Both cell populations showed comparable
inhibition after treatment with IFN-y (Fig. 6). Continued
treatment with Cd2+ resulted in profound cytotoxicity in cells
transfected with the sense INDO construct (Fig. 7, right),
whereas the cells transfected with the antisense construct
continued to grow normally (Fig. 7, left), indicating that the
cytotoxicity observed was not due to the presence of Cd2 .
Both cell populations showed similar cytotoxicity in response
























FIG. 6. Incorporation of [3H]thymidine into cells transfected with
the sense construct (A) or antisense construct (B) of INDO cDNA
after treatment with IFN-y (250 U/ml) or CdCl2 (5 jiM) for 3 days
compared with the corresponding controls (Con). The average counts
in control samples were normalized to 100%, and the relative values in
different samples were calculated. Error bars represent SD.
VOL. 62, 1994
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Antisense Sense
CON
FIG. 7. Effect of IFN-y and CdCI2 on the growth and survival of cells transfected with the INDO sense construct (right panels) or antisense
construct (left panels). See Materials and Methods for details. Cells were treated for 6 days before pictures were taken. CON, control.
inhibitory and cytotoxic effects of IFN--y could be reproduced
by the expression of INDO enzyme alone (Fig. 6 and 7).
DISCUSSION
The antimicrobial activities of IFN--y have been correlated
with the activation of various different mechanisms. In order to
assess the relative importance of these effector mechanisms, it
is important to determine the role of each pathway indepen-
dent of other IFN-induced mechanisms. We have tested
whether expression of INDO enzyme in cells transfected with
INDO cDNA in an expression vector would block the growth
of two pathogens, C. psittaci and T. gondii, in the absence of
IFN-y. The results presented here demonstrate that the growth
of the two microbes was strongly inhibited by the expression of
INDO activity. In experiments with C. psittaci, the inhibition of
the microbe was closely correlated with the induction of INDO
activity, as reflected by tryptophan degradation, and could be
reversed by the addition of excess tryptophan to the medium
(Fig. 4 and 5). These results provide strong support to the view
that induction of INDO enzyme is an important factor in the
antimicrobial activity of IFN--y. Earlier studies showed that
purified recombinant murine IFN--y did not induce measurable
levels of INDO activity in murine fibroblasts and failed to
inhibit the growth of T. gondii (32). Expression of INDO
activity in mouse cells by transfection conferred inhibition of T.
gondii growth (15), indicating an important role for INDO
expression in the inhibition of T. gondii. Our results with
INDO-transfected human fibroblasts support this conclusion
and are in agreement with the recent report that mutant
human cells deficient in IFN-y-induced expression of the
INDO gene showed reduced capacity to suppress Chlamydia
and Toxoplasma growth (35a).
The results presented here also showed that expression of
INDO activity alone from transfected cDNA resulted in the
inhibition of cell growth and led to cytotoxicity, as shown
earlier with IFN-y (9, 25, 30, 35, 36). Thus, the antiproliferative
and cytotoxic effects of IFN-,y may be due in part to the
induction of INDO and the resulting starvation for tryptophan,
an essential amino acid.
IFN-y, produced by activated T cells and natural killer cells,
is a pleiotropic cytokine with multiple biological activities. The
biological effects of IFN--y are apparently mediated through
the induction of multiple cellular genes. The fact that the
expression of INDO alone could reproduce some of the
biological effects of IFN-,y suggests that it may be an important
factor in the biological activities of IFN--y. It is not implied,
however, that INDO induction is the sole mechanism for the
antimicrobial activity of IFN-y. Other mechanisms activated by
IFN--y may be equally important in host defense against
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microbial pathogens in different cell types and different host
species. The induction of INDO by IFN-y may also play a role
in the pathogenesis of certain diseases. For example, increased
levels of IFN-y have been found in the serum of AIDS patients
who are seropositive for human immunodeficiency virus type 1
antibodies (13), which has been correlated with reduced levels
of tryptophan and serotonin (a product derived from trypto-
phan) in these patients, apparently due to the induction of
INDO by circulating IFN-y (12, 20). Furthermore, greatly
increased levels of quinolinic acid, a neurotoxic metabolite of
tryptophan, have been found in the serum and cerebrospinal
fluid of AIDS patients, especially those with neurological
dysfunction, i.e., AIDS dementia complex (17, 18), suggesting
a correlation. Increased INDO activity and toxic levels of
quinolinic acid were also found in the spinal cord and the
cerebrospinal fluid of macaques infected with poliovirus, sug-
gesting a possible role in neurological disease (19). Therefore,
the induction of INDO activity by IFN-y may be a significant
factor in the physiological resistance to pathogens as well as
the pathogenesis of various diseases involving IFN--y.
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